<DOC>
	<DOCNO>NCT00717769</DOCNO>
	<brief_summary>The purpose study explore efficacy safety SUN13834 v placebo adult subject atopic dermatitis</brief_summary>
	<brief_title>A Multicenter , Randomized , Placebo-Controlled , Double-Blind Study SUN13834 Adult Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female subject 18 65 year age ( inclusive ) . A diagnosis AD , meet Guidelines Diagnosis Atopic Dermatitis criterion Taking systemic immunosuppressive drug biologicals ( within 3 month ) , systemic corticosteroid therapy ( within 4 week ) prior Screening ( note : inhale , intranasal otic corticosteroid allow ) . Use phototherapy tan bed within 6 week screen History reactive airway disease ( asthma ) require hospitalization intensive care unit last 5 year . Presence clinically significant disorder involve cardiovascular , respiratory , renal , gastrointestinal , immunologic , hematologic , endocrine , neurologic system ( ) psychiatric disease ( determined Clinical Investigator ) interfere interpretation data patient ( eg , renal impairment nonatopic pruritis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>